Weight-loss medications
Wegovy pill vs Foundayo: 13.6% vs 11.2% average weight loss in trials. Wegovy pill needs an empty stomach; Foundayo can be taken any time.
Weight-loss medications
Three oral GLP-1 weight-loss pills compared. Wegovy pill (13.6%) and Foundayo (11.2%) expected in UK late 2026 and 2027; Rybelsus available now for type 2.
Vegetarian/vegan
A vegetarian recipe with red pepper, cherry tomatoes, and tin chopped tomatoes. Ready in 60 mins. Serves 4. Developed by Second Nature dietitians.
Sides, sauces and dips
A vegetarian side with uncooked quinoa, rocket, and spinach. Ready in 30 mins. Serves 4. Developed by Second Nature dietitians.
Lamb
A gluten-free lamb recipe with lamb mince, carrots, and ras el hanout seasoning. Ready in 40 mins. Serves 4. Developed by Second Nature dietitians.
Sides, sauces and dips
A gluten-free side with prawns, avocado, and little gem lettuces. Ready in under 15 mins. Serves 2. Developed by Second Nature dietitians.
Breakfast and eggs
A gluten-free breakfast with corn on the cob, vine cherry tomatoes, and cauliflower rice. Ready in 30 mins. Serves 2. Developed by Second Nature.
Weight-loss medications
Foundayo (orforglipron) is a daily GLP-1 pill for weight loss with no fasting requirements. FDA-approved April 2026. Average weight loss 11.2% at 72 weeks.
Current Health
New research finds GLP-1 users are judged more harshly than dieters, and sometimes more than people who haven't lost weight. Here's what the study shows.
Weight-loss medications
Retatrutide produced 28.7% weight loss in trials vs Wegovy 7.2 mg's 20.7%. Retatrutide isn't UK-approved yet; Wegovy is the current option.
As seen on
As seen on